| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Penny Asbell | Q43109114 |
| P2093 | author name string | Yi Wei | |
| P2860 | cites work | The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 |
| Strain-related cytokine profiles on the murine ocular surface in response to desiccating stress | Q80382639 | ||
| Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation | Q81131963 | ||
| Resolvins as new fascinating drug candidates for inflammatory diseases | Q83381326 | ||
| IL-7 drives Th1 and Th17 cytokine production in patients with primary SS despite an increase in CD4 T cells lacking the IL-7Rα | Q83388831 | ||
| Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests | Q83419797 | ||
| Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays | Q84579952 | ||
| Exposure to a dry environment induces strain-specific responses in mice | Q94520420 | ||
| sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model | Q24635932 | ||
| Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation | Q24683293 | ||
| Neurturin-Deficient Mice Develop Dry Eye and Keratoconjunctivitis Sicca | Q28204835 | ||
| Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures | Q28393435 | ||
| Selenium compound protects corneal epithelium against oxidative stress | Q28484037 | ||
| Dietary lactoferrin alleviates age-related lacrimal gland dysfunction in mice | Q28730905 | ||
| Progress and challenges in translating the biology of atherosclerosis | Q29619982 | ||
| Acupuncture for dry eye: a randomised controlled trial protocol | Q33552734 | ||
| Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome | Q33592784 | ||
| HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease | Q33861286 | ||
| Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease | Q33869200 | ||
| Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway | Q33938235 | ||
| Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice | Q34019278 | ||
| Characterization of effector T cells in dry eye disease | Q34065949 | ||
| Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca | Q34110644 | ||
| Oxidative stress induced inflammation initiates functional decline of tear production | Q34446876 | ||
| IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer | Q34448523 | ||
| Dry eye as a mucosal autoimmune disease | Q34647761 | ||
| Apoptosis as a therapeutic tool in rheumatoid arthritis | Q34718143 | ||
| Topical omega-3 and omega-6 fatty acids for treatment of dry eye. | Q34749224 | ||
| Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? | Q34952967 | ||
| Interferon-γ-secreting NK cells promote induction of dry eye disease | Q35001933 | ||
| Nutritional supplements for dry eye syndrome | Q35163639 | ||
| Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome | Q35674608 | ||
| Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease | Q35907009 | ||
| Efficacy of topical blockade of interleukin-1 in experimental dry eye disease | Q36044544 | ||
| Toll-like receptor expression and activation in mice with experimental dry eye. | Q36159551 | ||
| An immunoprotective privilege of corneal epithelial stem cells against Th17 inflammatory stress by producing glial cell-derived neurotrophic factor | Q36625070 | ||
| Autoimmunity at the ocular surface: pathogenesis and regulation | Q36625074 | ||
| Tear cytokine profiles in dysfunctional tear syndrome. | Q36637791 | ||
| IL-17 disrupts corneal barrier following desiccating stress. | Q36676135 | ||
| Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice. | Q36907644 | ||
| Dry eye disease: an immune-mediated ocular surface disorder | Q36916372 | ||
| Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye. | Q36989668 | ||
| Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease | Q37013881 | ||
| Chronic dry eye disease is principally mediated by effector memory Th17 cells | Q37067291 | ||
| Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression | Q37071969 | ||
| Dry eyes: etiology and management | Q37188359 | ||
| Advances in understanding and managing dry eye disease | Q37206550 | ||
| Tearful relations: oxidative stress, inflammation and eye diseases | Q37410898 | ||
| Rationale for anti-inflammatory therapy in dry eye syndrome | Q37410903 | ||
| Immunoregulation on the ocular surface: 2nd Cullen Symposium | Q37453762 | ||
| Induction of Th17 differentiation by corneal epithelial-derived cytokines | Q37462911 | ||
| Essential fatty acids for dry eye: A review | Q37661830 | ||
| Essential fatty acids in the treatment of dry eye. | Q37682316 | ||
| sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised | Q37726033 | ||
| Dry eye disease as an inflammatory disorder | Q37756166 | ||
| IL-6 induction in desiccated corneal epithelium in vitro and in vivo. | Q38608898 | ||
| Effect of hyperosmolality on beta-defensin gene expression by human corneal epithelial cells | Q39242998 | ||
| Interferon-gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells. | Q40930968 | ||
| Spontaneous T cell mediated keratoconjunctivitis in Aire-deficient mice. | Q41658848 | ||
| Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group | Q41730611 | ||
| Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. | Q42173370 | ||
| Role of Th17 cells in the immunopathogenesis of dry eye disease | Q42694095 | ||
| A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans | Q43723433 | ||
| Impaired neurotransmission in lacrimal and salivary glands of a murine model of Sjögren's syndrome. | Q44339277 | ||
| Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface | Q45158772 | ||
| Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2. | Q45930063 | ||
| Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. | Q45950875 | ||
| Autoantibodies contribute to the immunopathogenesis of experimental dry eye disease. | Q46073610 | ||
| A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome | Q46321286 | ||
| Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye. | Q46466345 | ||
| The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy | Q46658333 | ||
| Apoptosis in the lacrimal gland and conjunctiva of dry eye dogs | Q47947600 | ||
| Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. | Q50721017 | ||
| Increased eotaxin in tears of patients wearing contact lenses. | Q51594737 | ||
| Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. | Q53572321 | ||
| Isoforms of secretory group two phospholipase A (sPLA2) in mouse ocular surface epithelia and lacrimal glands. | Q54316515 | ||
| Analysis of inflammatory cytokines in the tears of dry eye patients. | Q54467014 | ||
| Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome. | Q54602794 | ||
| Inflammatory Markers in the Tears of Patients with Ocular Surface Disease | Q58979336 | ||
| Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca | Q72993423 | ||
| P433 | issue | 4 | |
| P921 | main subject | inflammation | Q101991 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 248-256 | |
| P577 | publication date | 2014-07-01 | |
| P1433 | published in | Eye and Contact Lens | Q15765460 |
| P1476 | title | The core mechanism of dry eye disease is inflammation | |
| P478 | volume | 40 |
| Q41442733 | A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment |
| Q33837188 | A novel TRPM8 agonist relieves dry eye discomfort |
| Q36304636 | Assessment of Corneal Biomechanical Properties by CorVis ST in Patients with Dry Eye and in Healthy Subjects |
| Q60046536 | Association between dry eye disease and asthma: a nationwide population-based study |
| Q89875479 | Associations Between Systemic Omega-3 Fatty Acid Levels With Moderate-to-Severe Dry Eye Disease Signs and Symptoms at Baseline in the Dry Eye Assessment and Management Study |
| Q50079417 | Calcitriol, the Active Metabolite of Vitamin D3, Inhibits Dry Eye Related Corneal Inflammation In Vivo and In Vitro. |
| Q38733230 | Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting |
| Q89689464 | Comparative lipidomic analysis of inflammatory mediators in the aqueous humor and tear fluid of humans and rabbits |
| Q36656777 | Comparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping |
| Q95729513 | Conjunctival HLA-DR Expression and Its Association With Symptoms and Signs in the DREAM Study |
| Q46718255 | Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease |
| Q57171838 | Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics |
| Q92824372 | Dry Eye Disease: A Review of Epidemiology in Taiwan, and its Clinical Treatment and Merits |
| Q37485819 | Effect of trapping vascular endothelial growth factor-A in a murine model of dry eye with inflammatory neovascularization |
| Q36137428 | Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial |
| Q55112422 | Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity. |
| Q26764956 | Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure |
| Q36393194 | Improvement in the signs and symptoms of dry eye disease with dobesilate eye drops |
| Q35825881 | Lipopolysaccharide challenge significantly influences lipid metabolism and proteome of white adipose tissue in growing pigs |
| Q38663883 | MAPK signaling pathways in eye wounds: Multifunction and cooperation |
| Q47442388 | Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation. |
| Q36559274 | Ocular Surface Epithelial Thickness Evaluation in Dry Eye Patients: Clinical Correlations |
| Q36931629 | Oral supplementation with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: results of a prospective study |
| Q52608828 | Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye. |
| Q52558847 | Phosphosulindac is efficacious in an improved concanavalin A-based rabbit model of chronic dry eye disease. |
| Q57593860 | Randomised masked trial of the clinical safety and tolerability of MGO Manuka Honey eye cream for the management of blepharitis |
| Q35928340 | Serum 25-Hydroxyvitamin D Levels and Dry Eye Syndrome: Differential Effects of Vitamin D on Ocular Diseases. |
| Q47203561 | Serum components and clinical efficacies of autologous serum eye drops in dry eye patients with active and inactive Sjogren syndrome |
| Q37084310 | Static and Dynamic Measurement of Ocular Surface Temperature in Dry Eyes. |
| Q90481097 | TRPV1 and TRPM8 Channels and Nocifensive Behavior in a Rat Model for Dry Eye |
| Q92543230 | Tear osmolarity after cataract surgery |
| Q33838529 | The Effect of Dry Eye Disease on Scar Formation in Rabbit Glaucoma Filtration Surgery |
| Q33756582 | The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research |
| Q90351231 | The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options |
| Q90627752 | The Role of SKQ1 (Visomitin) in Inflammation and Wound Healing of the Ocular Surface |
| Q48344821 | The Use of Topical Corticosteroids for Treatment of Dry Eye Syndrome. |
| Q50110517 | Therapeutic inhibitors for the treatment of dry eye syndrome. |
| Q42078385 | Therapeutic potential of Polyalthia cerasoides stem bark extracts against oxidative stress and nociception |
| Q55009490 | Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study. |
| Q38787674 | Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease. |
| Q88350776 | n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease |
| Q36388893 | α-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways |
Search more.